Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard Morton

Showing results (51-60 of 122) with videos related to

Pageof 13
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 8, 2011
Long-term results of a phase II trial of ultrasound-guided radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (RTOG 98-05)Colleen A Lawton, Daniel Hunt, W Robert Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|November 18, 2005
A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: preliminary results of RTOG P-0019W Robert Lee, Michelle DeSilvio, Colleen Lawton, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2022
An Updated Analysis of the Survival Endpoints of ASCENDE-RTJustin Oh, Scott Tyldesley, Howard Pai, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 1, 2019
MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): Results from a phase II clinical trialYasir Alayed, Laura D'Alimonte, Joelle Helou, et al.
Cancer|March 7, 2007
Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019W Robert Lee, Kyoungwha Bae, Colleen Lawton, et al.
Practical Radiation Oncology|May 20, 2019
5-Year Outcomes of a Prospective Phase 1/2 Study of Accelerated Hypofractionated Radiation Therapy to the Prostate BedKevin Martell, Patrick Cheung, Gerard Morton, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2005
Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancerPatrick Cheung, Katharina Sixel, Gerard Morton, et al.
Brachytherapy|November 16, 2017
Pattern of relapse and dose received by the recurrent intraprostatic nodule in low- to intermediate-risk prostate cancer treated with single fraction 19 Gy high-dose-rate brachytherapyLucas C Mendez, Ananth Ravi, Hans Chung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 16, 2015
High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of successJoelle Helou, Laura D'Alimonte, Andrew Loblaw, et al.
Brachytherapy|October 6, 2018
Clinical evaluation of an MRI-to-ultrasound deformable image registration algorithm for prostate brachytherapyAmani Shaaer, Melanie Davidson, Mark Semple, et al.
Pageof 13

Showing results (51-60 of 122) with videos related to

Sort By:
Pageof 13
International Journal of Radiation Oncology, Biology, Physics|April 8, 2011
Long-term results of a phase II trial of ultrasound-guided radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (RTOG 98-05)Colleen A Lawton, Daniel Hunt, W Robert Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|November 18, 2005
A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: preliminary results of RTOG P-0019W Robert Lee, Michelle DeSilvio, Colleen Lawton, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2022
An Updated Analysis of the Survival Endpoints of ASCENDE-RTJustin Oh, Scott Tyldesley, Howard Pai, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 1, 2019
MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): Results from a phase II clinical trialYasir Alayed, Laura D'Alimonte, Joelle Helou, et al.
Cancer|March 7, 2007
Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019W Robert Lee, Kyoungwha Bae, Colleen Lawton, et al.
Practical Radiation Oncology|May 20, 2019
5-Year Outcomes of a Prospective Phase 1/2 Study of Accelerated Hypofractionated Radiation Therapy to the Prostate BedKevin Martell, Patrick Cheung, Gerard Morton, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2005
Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancerPatrick Cheung, Katharina Sixel, Gerard Morton, et al.
Brachytherapy|November 16, 2017
Pattern of relapse and dose received by the recurrent intraprostatic nodule in low- to intermediate-risk prostate cancer treated with single fraction 19 Gy high-dose-rate brachytherapyLucas C Mendez, Ananth Ravi, Hans Chung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 16, 2015
High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of successJoelle Helou, Laura D'Alimonte, Andrew Loblaw, et al.
Brachytherapy|October 6, 2018
Clinical evaluation of an MRI-to-ultrasound deformable image registration algorithm for prostate brachytherapyAmani Shaaer, Melanie Davidson, Mark Semple, et al.
Pageof 13